Lantern Pharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EMPERY ASSET MANAGEMENT, LP | 08/11/2026 | 842.67 K | $3.51 M | 100.00% | 6.78% |
| CM MANAGEMENT, LLC | 08/13/2026 | 500.00 K | $2.09 M | 100.00% | 4.02% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 425.12 K | $1.77 M | 28.02% | 3.42% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 291.04 K | $1.21 M | 150.90% | 2.34% |
| BIOS CAPITAL MANAGEMENT, LP | 08/14/2026 | 249.40 K | $1.04 M | -71.15% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 102.82 K | $428.85 K | -7.91% | 0.83% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 49.95 K | $208.29 K | 0.69% | 0.40% |
| CITADEL ADVISORS LLC | 09/02/2026 | 47.90 K | $199.72 K | 100.00% | 0.39% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 07/27/2026 | 47.85 K | $199.54 K | -4.40% | 0.39% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 39.59 K | $165.10 K | 100.00% | 0.32% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 27.05 K | $112.80 K | -1.28% | 0.22% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 08/11/2026 | 25.16 K | $104.93 K | -4.58% | 0.20% |
| DAVENPORT & CO LLC | 07/13/2026 | 23.81 K | $99.30 K | 0.00% | 0.19% |
| STATE STREET CORP | 08/07/2026 | 23.65 K | $98.63 K | 0.00% | 0.19% |
| BLACKROCK, INC. | 08/07/2026 | 22.35 K | $93.20 K | -50.63% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 21.30 K | $88.83 K | 0.00% | 0.17% |
| NORTHERN TRUST CORP | 08/13/2026 | 17.49 K | $72.91 K | 12.16% | 0.14% |
| XTX TOPCO LTD | 08/14/2026 | 17.42 K | $72.62 K | 100.00% | 0.14% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 16.73 K | $69.74 K | -56.06% | 0.13% |
| UBS GROUP AG | 08/13/2026 | 16.63 K | $69.36 K | 65.05% | 0.13% |
| COLONY GROUP, LLC | 08/12/2026 | 15.43 K | $64.35 K | 0.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 14.07 K | $58.68 K | 100.00% | 0.11% |
| CETERA INVESTMENT ADVISERS | 08/12/2026 | 12.23 K | $50.99 K | 0.00% | 0.10% |
| MARSHALL WACE, LLP | 08/13/2026 | 11.95 K | $49.82 K | 100.00% | 0.10% |
| FARTHER FINANCE ADVISORS, LLC | 07/17/2026 | 10.98 K | $45.77 K | 100.00% | 0.09% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 2.36 K | $9.82 K | 0.00% | 0.02% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 2.34 K | $9.75 K | 2,084.11% | 0.02% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 2.16 K | $9.00 K | 0.70% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.16 K | $4.85 K | -67.44% | 0.01% |
| MORGAN STANLEY | 08/13/2026 | 639 | $2.67 K | 6.32% | 0.01% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 500 | $2.09 K | 0.00% | 0.00% |
| ENTRUST FINANCIAL LLC | 07/20/2026 | 500 | $2.09 K | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 220 | $917 | 0.00% | 0.00% |
| PHYSICIAN WEALTH ADVISORS, INC. | 07/20/2026 | 158 | $659 | 100.00% | 0.00% |
| RIALTO WEALTH MANAGEMENT, LLC | 08/11/2026 | 123 | $513 | 100.00% | 0.00% |
| PLANVEST FINANCIAL, INC | 08/10/2026 | 100 | $417 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 23 | $96 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 6 | $25 | 100.00% | 0.00% |
| KEY FINANCIAL INC | 07/24/2026 | 2 | $8 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| VOSS CAPITAL, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CURIO WEALTH, LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lantern Pharma Inc institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Lantern Pharma Inc. The most heavily invested institutionals were:
Empery Asset Management, LP: 842,669
CM Management, LLC: 500,000
VANGUARD CAPITAL MANAGEMENT LLC: 425,118
RENAISSANCE TECHNOLOGIES LLC: 291,039
BIOS Capital Management, LP: 249,397
GEODE CAPITAL MANAGEMENT, LLC: 102,819
23.21% of Lantern Pharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.32 M shares in the last 24 months. This purchase volume represents approximately $9.10 M in transactions.